Open Access
Immune checkpoint inhibitor–related eruptive keratoacanthoma
Canadian Medical Association Journal · 01.06.2026 · 198 (21) · E836-E837
DOI: 10.1503/cmaj.252150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Medical Association Journal, online erschienen am 31.05.2026. Verfasst von Kazuki Watanabe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Chitose City Hospital, Chitose, Japan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, Chitose City Hospital, Chitose, Japan.
- Department of Dermatology, Chitose City Hospital, Chitose, Japan. ota@med.hokudai.ac.jp.
Zitieren
APA
Watanabe, K., & Ota, M. (2026). Immune checkpoint inhibitor–related eruptive keratoacanthoma. Canadian Medical Association Journal, 198(21), E836-E837. https://doi.org/10.1503/cmaj.252150
Vancouver
Watanabe K, Ota M. Immune checkpoint inhibitor–related eruptive keratoacanthoma. Canadian Medical Association Journal. 2026;198(21):E836-E837. doi:10.1503/cmaj.252150
BibTeX
@article{Watanabe2026,
author = {Watanabe, Kazuki and Ota, Mitsuhito},
title = {Immune checkpoint inhibitor–related eruptive keratoacanthoma},
journal = {Canadian Medical Association Journal},
year = {2026},
volume = {198},
number = {21},
pages = {E836--E837},
doi = {10.1503/cmaj.252150}
}
EUVIMED